BOT 2.63% 37.0¢ botanix pharmaceuticals ltd

Ann: Final Sofdra Labelling Discussions with FDA, page-76

  1. 1,880 Posts.
    lightbulb Created with Sketch. 1291



    Indeed - It's what happens after we get FDA Approval for Sofdra that is the exciting bit. That's the bit missing from anybody's assessment who thinks 'Approval' is built into today's price.

    21 June is a big date indeed, but not for the reasons most punters think - Sofdra. That is just the starting gun! Approval for Sofdra means BOT has the green light to proceed with the pipeline. That's what will spark the increase come approval day - once income is assured from Approval, the market will have confidence the pipeline is going to be off and running!

    As soon as BOT gets approval for Sofdra, they will move to sales. Sales are guaranteed - it's just how much that is speculated on. Nonetheless, whatever it is, it's going to be enough for the company to keep running and to then focus on furthering the Phase 3 Acne Trial and the further trials for Rosacea and Anti-microbial. I think that's so much more exciting that simple old FDA Approval for Sofdra! Even though Sofdra could make hundreds of millions.
    Last edited by Grainofsand: 12/06/24
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
37.0¢
Change
-0.010(2.63%)
Mkt cap ! $669.7M
Open High Low Value Volume
38.0¢ 38.5¢ 36.5¢ $2.548M 6.766M

Buyers (Bids)

No. Vol. Price($)
2 96148 36.5¢
 

Sellers (Offers)

Price($) Vol. No.
37.0¢ 782479 9
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.